Essex LLC Sells 95 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Essex LLC trimmed its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 5.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,801 shares of the financial services provider’s stock after selling 95 shares during the period. Essex LLC’s holdings in iShares Biotechnology ETF were worth $238,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the third quarter worth $29,000. Highline Wealth Partners LLC bought a new stake in iShares Biotechnology ETF in the third quarter worth about $30,000. HHM Wealth Advisors LLC boosted its position in shares of iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after buying an additional 150 shares during the period. Hager Investment Management Services LLC purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter worth approximately $34,000. Finally, Ashton Thomas Securities LLC purchased a new position in iShares Biotechnology ETF during the 3rd quarter valued at $36,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 2.1 %

IBB stock opened at $137.67 on Friday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The business’s fifty day simple moving average is $136.22 and its two-hundred day simple moving average is $141.38.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.